These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2792354)

  • 1. [Comparative evaluation of the anticoagulant activity of the sodium and calcium salts of heparin, isolated from swine intestinal mucosa].
    Ushkalova EA; Kremneva VF; Ovchinnikova LK; Shcheglova NV
    Farmakol Toksikol; 1989; 52(3):51-5. PubMed ID: 2792354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a new potent heparin. 6th communication: The comparison of the anticoagulant effect of the sodium and calcium salts of a new potent heparin after s.c. injection in beagle dogs.
    Bhargava AS; Schöbel C; Günzel P
    Arzneimittelforschung; 1981; 31(1):79-82. PubMed ID: 7194097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of the Soviet antimalarial preparation dabequin on the hemostatic system and on the anticoagulant effect of heparin].
    Pomortseva IV; Ovchinnikova LK; Shcheglova NV
    Farmakol Toksikol; 1990; 53(1):59-62. PubMed ID: 2328805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated coagulation time in monitoring heparinized dogs.
    Green RA
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of low-dose subcutaneous heparin calcium and heparin sodium on ecchymosis formation.
    Barbaccia JG; Perry WR; Dellatore C; Mendelson S
    Clin Pharm; 1984; 3(2):184-6. PubMed ID: 6723225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of isoptin on the anticoagulant effect of the sodium and calcium salts of heparin].
    Ushkalova EA; Kremneva VF; Shcheglova NV
    Farmakol Toksikol; 1988; 51(3):48-51. PubMed ID: 3410026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of low-dose sodium and calcium heparin on the reticuloendothelial system and granulocyte function in man. An in vivo and in vitro study.
    Berghem L; Lahnborg G; Jarstrand C
    Acta Chir Scand; 1982; 148(7):563-7. PubMed ID: 6762791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of the joint administration of heparin and chitosan sulfate ether on hemostatic function].
    Drozd NN; Makarov VA; Bashkov GV; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1996; 59(1):30-3. PubMed ID: 8704629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local tolerance of subcutaneous heparin. Double-blind comparison of calcium and sodium heparins (author's transl)].
    Blard JM; Rincon F; Nakache JP; Chastang C
    Sem Hop; 1979 Jan 8-15; 55(1-2):45-9. PubMed ID: 218296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals].
    Kudriashov BA; Pastorova VE; Liapina LA
    Vopr Med Khim; 1985; 31(3):37-41. PubMed ID: 4024529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant activity of two commercially available heparin preparations. A controlled study.
    Gomez-Perez F
    J Clin Pharmacol New Drugs; 1972 Oct; 12(10):413-6. PubMed ID: 4484532
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies in man and experimental animals of a low molecular weight heparin fraction.
    Thomas DP; Merton RE; Lewis WE; Barrowcliffe TW
    Thromb Haemost; 1981 Jun; 45(3):214-8. PubMed ID: 7281101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
    Hellebrekers LJ; Slappendel RJ; van den Brom WE
    Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.
    Grimaudo V; Omri A; Kruithof EK; Hauert J; Bachmann F
    Thromb Haemost; 1988 Jun; 59(3):388-91. PubMed ID: 2847348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of heparin from tuna skins.
    Jeske WP; McDonald MK; Hoppensteadt DA; Bau EC; Mendes A; Dietrich CP; Walenga JM; Coyne E
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):137-45. PubMed ID: 17456622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a high single subcutaneous dose of unfractionated heparin on platelet function in dogs].
    Mischke R; Nimmerfall K
    Berl Munch Tierarztl Wochenschr; 2000 Feb; 113(2):60-4. PubMed ID: 10726363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic and anticoagulant activities of a low molecular weight fucoidan by the subcutaneous route.
    Millet J; Jouault SC; Mauray S; Theveniaux J; Sternberg C; Boisson Vidal C; Fischer AM
    Thromb Haemost; 1999 Mar; 81(3):391-5. PubMed ID: 10102467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of delagil on the blood coagulation system and the interrelation with heparin].
    Ovchinnikova LK; Pomortseva IV
    Farmakol Toksikol; 1985; 48(2):77-81. PubMed ID: 3996575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.